PHPhilip J. Hogarth

Philip J. Hogarth

*This is an algorithmically generated author record based on publicly available information.

Philip J. Hogarth has a total of 86 co-authors. Here are the top co-authors by number of shared publications:

  • Daryan A. Kaveh

    Department of Bacteriology, Animal & Plant Health Agency (APHA), Woodham Lane, Addlestone, Surrey KT15 3NB, United Kingdom(1)

    8 shared publications
  • H. Martin Vordermeier

    Department of Bovine Tuberculosis, Animal Health and Veterinary Laboratories Agency, Surrey, United Kingdom

    5 shared publications
  • R. Glyn Hewinson

    TB Research Group, Animal Health and Veterinary Laboratories Agency (AHVLA), Addlestone, Surrey, United Kingdom

    5 shared publications
  • M. Carmen Garcia-Pelayo

    Vaccine Immunology Team, Department of Bacteriology, Animal & Plant Health Agency (APHA), Addlestone, Surrey, UK

    4 shared publications
  • Mark Andrew Chambers

    Affiliations School of Veterinary Medicine, University of Surrey, Guildford, United Kingdom, School of Biosciences, University of Surrey, Guildford, United Kingdom

    4 shared publications
  • Véronique S. Bachy

    Department of Bacteriology, Animal & Plant Health Agency (APHA), Woodham Lane, Addlestone, Surrey KT15 3NB, United Kingdom(1)

    4 shared publications

Latest Publications

  • Open Access

    Inferring Mycobacterium bovis transmission between cattle and badgers using isolates from the Randomised Badger Culling Trial

    by Andries J. van Tonder, Mark Thornton, Andrew J.K. Conlan, Keith A. Jolley, Lee Goolding, Andrew P. Mitchell, James Dale, Eleftheria Palkopoulou, Philip J. Hogarth, R. Glyn Hewinson, et al.

    Mycobacterium bovis ( M. bovis) is a causative agent of bovine tuberculosis, a significant source of morbidity and mortality in the global cattle industry. The Randomised Badger Culling Trial was a field experiment carried out between 1998 and 2005 in the South West of England. As part of this trial, M. bovis isolates were collected from contemporaneous and overlapping populations of badgers and cattle within ten defined trial areas. We combined whole genome sequences from 1,442 isolates with location and cattle movement data, identifying transmission clusters and inferred rates and routes of transmission of M. bovis . Most trial areas contained a single transmission cluster that had been established shortly before sampling, often contemporaneous with the expansion of bovine tuberculosis in the 1980s. The estimated rate of transmission from badger to cattle was approximately two times higher than from cattle to badger, and the rate of within-species transmission considerably exceeded these for both species. We identified long distance transmission events linked to cattle movement, recurrence of herd breakdown by infection within the same transmission clusters and superspreader events driven by cattle but not badgers. Overall, our data suggests that the transmission clusters in different parts of South West England that are still evident today were established by long-distance seeding events involving cattle movement, not by recrudescence from a long-established wildlife reservoir. Clusters are maintained primarily by within-species transmission, with less frequent spill-over both from badger to cattle and cattle to badger.


  • Open Access

    Airway delivery of both a BCG prime and adenoviral boost drives CD4 and CD8 T cells into the lung tissue parenchyma

    by Daryan A. Kaveh, M. Carmen Garcia-Pelayo, Naomi C. Bull, Pedro J. Sanchez-Cordon, John Spiropoulos, Philip J. Hogarth

    Heterologous BCG prime-boost regimens represent a promising strategy for an urgently required improved tuberculosis vaccine. Identifying the mechanisms which underpin the enhanced protection induced by such strategies is one key aim which would significantly accelerate rational vaccine development. Experimentally, airway vaccination induces greater efficacy than parenteral delivery; in both conventional vaccination and heterologous boosting of parenteral BCG immunisation. However, the effect of delivering both the component prime and boost immunisations via the airway is not well known. Here we investigate delivery of both the BCG prime and adenovirus boost vaccination via the airway in a murine model, and demonstrate this approach may be able to improve the protective outcome over parenteral prime/airway boost. Intravascular staining of T cells in the lung revealed that the airway prime regimen induced more antigen-specific multifunctional CD4 and CD8 T cells to the lung parenchyma prior to challenge and indicated the route of both prime and boost to be critical to the location of induced resident T cells in the lung. Further, in the absence of a defined phenotype of vaccine-induced protection to tuberculosis; the magnitude and phenotype of vaccine-specific T cells in the parenchyma of the lung may provide insights into potential correlates of immunity.


  • Open Access

    Parenteral adenoviral boost enhances BCG induced protection, but not long term survival in a murine model of bovine TB

    by Daryan A. Kaveh, M. Carmen Garcia-Pelayo, Paul R. Webb, Esen E. Wooff, Véronique S. Bachy, Philip J. Hogarth


  • Open Access

    Phenotypic characterization of bovine memory cells responding to mycobacteria in IFNγ enzyme linked immunospot assays

    by Laura Blunt, Philip J. Hogarth, Daryan A. Kaveh, Paul Webb, Bernardo Villarreal-Ramos, Hans Martin Vordermeier


  • Open Access

    BALB/c mice display more enhanced BCG vaccine induced Th1 and Th17 response than C57BL/6 mice but have equivalent protection

    by M. Carmen Garcia-Pelayo, Véronique S. Bachy, Daryan A. Kaveh, Philip J. Hogarth


  • Open Access

    Persistent BCG bacilli perpetuate CD4 T effector memory and optimal protection against tuberculosis

    by Daryan A. Kaveh, M.C. Garcia-Pelayo, Philip J. Hogarth


  • Open Access

    International Society for the Advancement of Cytometry cell sorter biosafety standards

    by Kevin L. Holmes, Benjamin Fontes, Philip Hogarth, Richard Konz, Simon Monard, Charles H. Pletcher, Robert B. Wadley, Ingrid Schmid, Stephen P. Perfetto

    Flow cytometric cell sorting of biological specimens has become prevalent in basic and clinical research laboratories. These specimens may contain known or unknown infectious agents, necessitating precautions to protect instrument operators and the environment from biohazards arising from the use of sorters. To this end the International Society of Analytical Cytology (ISAC) was proactive in establishing biosafety guidelines in 1997 (Schmid et al., Cytometry 1997;28:99–117) and subsequently published revised biosafety standards for cell sorting of unfixed samples in 2007 (Schmid et al., Cytometry Part A J Int Soc Anal Cytol 2007;71A:414–437). Since their publication, these documents have become recognized worldwide as the standard of practice and safety precautions for laboratories performing cell sorting experiments. However, the field of cytometry has progressed since 2007, and the document requires an update. The new Standards provides guidance: (1) for laboratory design for cell sorter laboratories; (2) for the creation of laboratory or instrument specific Standard Operating Procedures (SOP); and (3) on procedures for the safe operation of cell sorters, including personal protective equipment (PPE) and validation of aerosol containment. Published © 2013 Wiley Periodicals Inc.†


  • Open Access

    Development of an Unbiased Antigen-Mining Approach To Identify Novel Vaccine Antigens and Diagnostic Reagents for Bovine Tuberculosis

    by Gareth J. Jones, Bhagwati L. Khatri, M. Carmen Garcia-Pelayo, Daryan A. Kaveh, Véronique S. Bachy, Philip J. Hogarth, Esen Wooff, Paul Golby, H. Martin Vordermeier

    Previous experiments for the identification of novel diagnostic or vaccine candidates for bovine tuberculosis have followed a targeted approach, wherein specific groups of proteins suspected to contain likely candidates are prioritized for immunological assessment (for example, with in silico approaches). However, a disadvantage of this approach is that the sets of proteins analyzed are restricted by the initial selection criteria. In this paper, we describe a series of experiments to evaluate a nonbiased approach to antigen mining by utilizing a Gateway clone set for Mycobacterium tuberculosis , which constitutes a library of clones expressing 3,294 M. tuberculosis proteins. Although whole-blood culture experiments using Mycobacterium bovis -infected animals and M. bovis BCG-vaccinated controls did not reveal proteins capable of differential diagnosis, several novel immunogenic proteins were identified and prioritized for efficacy studies in a murine vaccination/challenge model. These results demonstrate that Rv3329-immunized mice had lower bacterial cell counts in their spleens following challenge with M. bovis . In conclusion, we demonstrate that this nonbiased approach to antigen mining is a useful tool for identifying and prioritizing novel proteins for further assessment as vaccine antigens.


  • Immunogenicity comparison of the intradermal or endobronchial boosting of BCG vaccinates with Ad5-85A

    by Adam Whelan, Pinar Court, Zhou Xing, Derek Clifford, Philip J. Hogarth, Martin Vordermeier, Bernardo Villarreal-Ramos


  • Open Access

    The Duration of Antigen-Stimulation Significantly Alters the Diversity of Multifunctional CD4 T Cells Measured by Intracellular Cytokine Staining

    by Daryan A. Kaveh, Adam O. Whelan, Philip J. Hogarth

    The assessment of antigen-specific T cell responses by intracellular cytokine staining (ICS) has become a routine technique in studies of vaccination and immunity. Here, we highlight how the duration of in vitro antigen pre-stimulation, combined with the cytokine accumulation period, are critical parameters of these methods. The effect of varying these parameters upon the diversity and frequency of multifunctional CD4 T cell subsets has been investigated using a murine model of TB vaccination and in cattle naturally infected with Mycobacterium bovis. We demonstrate a substantial influence of the duration of the antigen pre-stimulation period on the repertoire of the antigen-specific CD4 T cell responses. Increasing pre-stimulation from 2 to 6 hours amplified the diversity of the seven potential multifunctional CD4 T cell subsets that secreted any combination of IFN-γ, IL-2 and TNF-α. However, increasing pre-stimulation from 6 to 16 hours markedly altered the multifunctional CD4 T cell repertoire to a dominant IFN-γ+ only response. This was observed in both murine and cattle models. Whilst these data are of particular relevance to the measurement of vaccine and infection induced immunity in TB, more generally, they demonstrate the importance of the empirical determination of the optimum duration of the individual culture steps of ICS assays for any model. We highlight the potential significance of variations in these parameters, particularly when comparing data between studies and/or models including clinical trials.